Abstrakt

Przypisy

• 1. Ait-Hsiko L., Kraaij T., Wedel J., Theisinger B., Theisinger S., YardB., Bugert P., Schedel A.: N-octanoyl-dopamine is a potent inhibitorof platelet function. Platelets, 2013; 24: 428-34
  Google Scholar
• 2. Bockenstedt P.L.: Thrombocytopenia in pregnancy. Hematol. Oncol.Clin. North Am., 2011; 25: 293-310
  Google Scholar
• 3. Boehlen F., Hohlfeld P., Extermann P., de Moerloose P.: Maternalantiplatelet antibodies in predicting risk of neonatal thrombocytopenia.Obstet. Gynecol., 1999; 93: 169-173
  Google Scholar
• 4. Boehlen F., Hohlfeld P., Extermann P., Perneger T.V., de MoerlooseP.: Platelet count at term pregnancy: a reappraisal of the threshold.Obstet. Gynecol., 2000; 95: 29-33
  Google Scholar
• 5. British Committee for Standards in Haematology General HaematologyTask Force: Guidelines for the investigation and managementof idiopathic thrombocytopenic purpura in adults, children and inpregnancy. Br. J. Haematol., 2003; 120: 574-596
  Google Scholar
• 6. Burrows R.F., Kelton J.G.: Thrombocytopenia at delivery: a prospectivesurvey of 6715 deliveries. Am. J. Obstet. Gynecol., 1990;162: 731-734
  Google Scholar
• 7. Chen Y.C., Chen H.S., Shen C.J., Chang H.M., Tsai E.M.: Delayedpostpartum hemorrhage – a rare clinical presentation of thromboticthrombocytopenic purpura-hemolytic uremic syndrome: a casereport. Kaohsiung J. Med. Sci., 2005; 21: 532-535
  Google Scholar
• 8. Chow L., Farber M.K., Camann W.R.: Anesthesia in the pregnantpatient with hematologic disorders. Hematol. Oncol. Clin. NorthAm., 2011; 25: 425-443
  Google Scholar
• 9. Davoren A., Bussel J., Curtis B.R., Moghaddam M., Aster R.H.,McFarland J.G.: Prospective evaluation of a new platelet glycoprotein(GP)-specific assay (PakAuto) in the diagnosis of autoimmunethrombocytopenia (AITP). Am. J. Hematol., 2005; 78: 193-197
  Google Scholar
• 10. Ducloy-Bouthors A.S., Caron C., Subtil D., Provot F., Tournoys A.,Wibau B., Krivosic-Horber R.: Thrombotic thrombocytopenic purpura:medical and biological monitoring of six pregnancies. Eur. J.Obstet. Gynecol. Reprod. Biol., 2003; 111: 146-152
  Google Scholar
• 11. George J.N., Woolf S.H., Raskob G.E., Wasser J.S., Aledort L.M.,Ballem P.J., Blanchette V.S., Bussel J.B., Cines D.B., Kelton J.G., LichtinA.E., McMillan R., Okerbloom J.A., Regan D.H., Warrier I.: Idiopathicthrombocytopenic purpura: a practice guideline developedby explicit methods for the American Society of Hematology. Blood,1996; 88: 3-40
  Google Scholar
• 12. Gerth J.; Schleussner E.; Kentouche K., Busch M., Seifert M., WolfG.: Pregnancy-associated thrombotic thrombocytopenic purpura.Thromb. Haemost., 2009; 101: 248-251References
  Google Scholar
• 13. Gude N.M., Roberts C.T., Kalionis B., King R.G.: Growth and functionof the normal human placenta. Thrombosis Res., 2004; 114:397-407
  Google Scholar
• 14. Habas E., Rayani A., Ganterie R.: Thrombocytopenia in hypertensivedisease of pregnancy. J Obstet. Gynaecol. India, 2013; 63: 96-100
  Google Scholar
• 15. Haumonte J.B., Caillat-Zucman S., Bretelle F., Lambert M., LyonnetL., Levy-Mozziconacci A., Farnarier C., Aubert A., Boubli L., Camoin-JauL., Dignat George F., Paul P.: Enhanced prevalence of plasmaticsoluble MHC class I chain-related molecule in vascular pregnancydiseases. Biomed. Res. Int., 2014; 2014: 653161
  Google Scholar
• 16. Hertig A., Fort J., Lefevre G., Chabbert-Buffet N., Uzan M., RondeauE., Rozenberg P.: Soluble endoglin in preeclamptic patients with orwithout HELLP syndrome. Am. J. Obstet. Gynecol., 2010; 202: 594.e1-4
  Google Scholar
• 17. Hulstein J.J., van Runnard Heimel P.J., Franx A., Lenting P.J., BruinseH.W., Silence K., de Groot P.G., Fijnheer R.: Acute activation ofthe endothelium results in increased levels of active von Willebrandfactor in hemolysis, elevated liver enzymes and low platelets (HELLP)syndrome. J. Thromb. Haemost., 2006; 4: 2569-2575
  Google Scholar
• 18. Kasai J., Aoki S., Kamiya N., Hasegawa Y., Kurasawa K., TakahashiT., Hirahara F.: Clinical features of gestational thrombocytopeniadifficult to differentiate from immune thrombocytopenia diagnosedduring pregnancy. J. Obstet. Gynaecol. Res., 2015; 41: 44-49
  Google Scholar
• 19. Kłósek A., Zimmer M., Hirnle L., Omanwa K., Tomiałowicz M.,Lindner K., Mazur G.: Małopłytkowość w ciąży – doświadczenia własne.Adv. Clin. Exp. Med., 2004; 13 (suppl. 1): 65-69
  Google Scholar
• 20. Koyama S., Tomimatsu T., Kanagawa T., Kumasawa K., Tsutsui T.,Kimura T.: Reliable predictors of neonatal immune thrombocytopeniain pregnant women with idiopathic thrombocytopenic purpura.Am. J. Hematol., 2012; 87: 15-21
  Google Scholar
• 21. Lee S.J., Kwon J.A., Cho S.A., Jarrar Y.B., Shin J.G.: Effects of testosteroneand 17β-oestradiol on expression of the G protein-coupledreceptor P2Y12 in megakaryocytic DAMI cells. Platelets, 2012;23: 579-585
  Google Scholar
• 22. Lescale K.B., Eddleman K.A., Cines D.B., Samuels P., Lesser M.L.,McFarland J.G., Bussel J.B.: Antiplatelet antibody testing in thrombocytopenicpregnant women. Am. J. Obstet. Gynecol., 1996; 174:1014-1018
  Google Scholar
• 23. Lim C.C., Patel D.K., Bakhtiari A., Subrayan V.: An unusual presentationof gestational thrombocytopenia. Platelets, 2013; 24: 498-499
  Google Scholar
• 24. Liu X.G.., Ren J., Yu Y., Sun L., Shi Y., Qin P., Yang L., Ma S.H., DongX.Y., Ma D.X., Qu X., Guo C.S., Chen C.Y., Hou M., Peng J.: Decreased expression of interleukin-27 in immune thrombocytopenia. Br. J.Haematol., 2011; 153: 259-267
  Google Scholar
• 25. Mao S.P., Chang C.C., Chen S.Y., Lai H.C.: Gestational thrombocytopeniacomplicated with macrosomia, failure to progress in activelabor and postpartum hemorrhage. Taiwan. J. Obstet. Gynecol.,2007; 46: 177-179
  Google Scholar
• 26. McCrae K.R.: Thrombocytopenia in pregnancy. Hematology. Am.Soc. Hematol. Educ. Program, 2010; 2010: 397-402
  Google Scholar
• 27. McMillan R.: The pathogenesis of chronic immune thrombocytopenicpurpura. Semin. Hematol., 2007; 44 (Suppl. 5): S3-S11
  Google Scholar
• 28. Mehta T., Parikh G.P., Shah V.R.: Triad of idiopathic thrombocytopenicpurpura, preeclampsia, and HELLP syndrome in a parturient:a rare confrontation to the anesthetist. Case Rep. Anesthesiol.,2014; 2014: 1394-1396
  Google Scholar
• 29. Myers B.: Diagnosis and management of maternal thrombocytopeniain pregnancy. Br. J. Haematol., 2012; 158: 3-15
  Google Scholar
• 30. Olayemi E., Akuffo F.W.: Gestational thrombocytopenia amongpregnant Ghanaian women. Pan Afr. Med. J., 2012; 12: 34
  Google Scholar
• 31. Onyangunga O.A., Moodley J.: Managing pregnancy with HIV,HELLP syndrome and low platelets. Best Pract. Res. Clin. Obstet.Gynaecol., 2012; 26: 133-147
  Google Scholar
• 32. Parnas M., Sheiner E., Shoham-Vardi I., Burstein E., YermiahuT., Levi I., Holcberg G., Yerushalmi R.: Moderate to severe thrombocytopeniaduring pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol.,2006; 128: 163-168
  Google Scholar
• 33. Perdomo J., Yan F., Ahmadi Z., Jiang X.M., Stocker R., ChongB.H.: Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production invitro. Blood, 2011; 117: 5975-5986
  Google Scholar
• 34. Rocha A.M., de Souza C., Rocha G.A., De Melo F.F., Saraiva I.S.,Clementino N.C., Marino M.C., Queiroz D.M.: IL1RN VNTR and IL2 330 polymorphic genes are independently associated with chronicimmune thrombocytopenia. Br. J. Haematol., 2010; 150: 679-684
  Google Scholar
• 35. Rodeghiero F., Besalduch J., Michel M., Provan D., GrotzingerK., Thompson G.: Treatment practices in adults with chronic immune thrombocytopenia – a European perspective. Eur. J. Haematol.,2010; 84: 160-168
  Google Scholar
• 36. Scully M., Hunt B.J., Benjamin S., Liesner R., Rose P., Peyvandi F.,Cheung B., Machin S.J. on behalf of British Committee for Standardsin Haematology: Guidelines on the diagnosis and management ofthrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Br. J. Haematol. 2012; 158: 323-335
  Google Scholar
• 37. Stavrou E., McCrae K.R.: Immune thrombocytopenia in pregnancy.Hematol. Oncol. Clin. North Am., 2009; 23: 1299-1316
  Google Scholar
• 38. Uhrynowska M., Maślanka K., Kopeć I., Sakiewicz J., Łopacz P.,Orzińska A., Brojer E.: Reticulated platelet count used for differentiationof the type of thrombocytopenia in pregnant women. Ginekol.Pol., 2012; 83: 265-269
  Google Scholar
• 39. Verdy E., Bessous V., Dreyfus M., Kaplan C., Tchernia G., UzanS.: Longitudinal analysis of platelet count and volume in normalpregnancy. Thromb. Haemost., 1997; 77: 806-807
  Google Scholar
• 40. Webert K.E., Mittal R., Sigouin C., Heddle N.M., Kelton J.G.: A retrospective11-year analysis of obstetric patients with idiopathicthrombocytopenic purpura. Blood, 2003; 102: 4306-4311
  Google Scholar
• 41. Win N., Rowley M., Pollard C., Beard J., Hambley H., Booker M.:Severe gestational (incidental) thrombocytopenia: to treat or notto treat. Hematology, 2005; 10: 69-72
  Google Scholar
• 42. Young B., Levine R.J., Salahuddin S., Qian C., Lim K.H., KarumanchiS.A., Rana S.: The use of angiogenic biomarkers to differentiatenon-HELLP related thrombocytopenia from HELLP syndrome. J.Matern. Fetal Neonatal Med., 2010; 23: 366-370
  Google Scholar
• 43. Yuce T., Acar D., Kalafat E., Alkilic A., Cetindag E., Soylemez F.:Thrombocytopenia in pregnancy: do the time of diagnosis and deliveryroute affect pregnancy outcome in parturients with idiopathicthrombocytopenic purpura? Int. J. Hematol., 2014; 100: 540-544
  Google Scholar
• 44. Zhou H., Qi A.P., Li H.Y., Ma L., Xu J.H, Xue F., Lu S.H, Zhao Q.J,Zhou Z.P., Yang R.C.: CD72 gene expression in immune thrombocytopenia.Platelets, 2012; 23: 638-44
  Google Scholar

Pełna treść artykułu